)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Theravance Biopharma
Theravance Biopharma (TBPH) investor relations material
Theravance Biopharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary25 Aug, 2026
Executive summary
A definitive proxy statement was filed regarding a proposed transaction with Zymeworks Inc., urging shareholders to review all related materials for important information.
The company presented results from the Phase 3 CYPRESS Study of ampreloxetine for symptomatic neurogenic orthostatic hypotension (nOH) in multiple system atrophy (MSA), including post hoc analyses and regulatory updates.
Forward-looking statements highlight risks and uncertainties, including shareholder approval, regulatory outcomes, and potential litigation related to the proposed transaction.
Voting matters and shareholder proposals
Shareholders are being solicited to vote on the proposed transaction with Zymeworks Inc., with details provided in the definitive proxy statement.
The interests of directors, executive officers, and certain employees in the transaction may differ from those of shareholders generally.
Executive compensation and say-on-pay
Information regarding the direct and indirect interests of directors and executive officers in the proposed transaction is available in the proxy statement.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Theravance Biopharma
- Shareholders to vote on $17.00 per share cash merger with Zymeworks and contingent value rights.TBPH
Proxy filing - Merger approval sought: $17/share cash plus CVR; board recommends, closing expected H2 2026.TBPHProxy filing
- Definitive merger with Zymeworks, 11% revenue growth, and major cost reductions in Q2 2026.TBPHQ2 2026
- Profitable COPD drug funds late-stage rare disease asset, with global launch plans and strong IP.TBPH7th Annual Evercore ISI HealthCONx Conference
- Merger agreement provides $17/share cash plus CVR for 80% of future ampreloxetine proceeds.TBPHProxy filing
- YUPELRI revenue up 15% YoY, net loss narrows, and restructuring targets major cost savings.TBPHQ1 2026
- Ampreloxetine targets a critical gap in MSA-related nOH, with pivotal data expected Q1 2026.TBPHKOL Event
- YUPELRI and TRELEGY sales rose, cash remains strong, and ampreloxetine advances in Phase 3.TBPHQ1 2025
- Record sales, milestone payments, and pipeline progress support growth and strategic options.TBPHQ4 2024
Next Theravance Biopharma earnings date
Q3 20262 Nov, 2026
Theravance Biopharma
Next Theravance Biopharma earnings date
Q3 20262 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage